Iran Health 2017: Gerresheimer to showcase its primary packaging made from glass
"We’re delighted to be presenting our products for the first time at this year’s Iran Health in Tehran," says Area Sales Manager Mehran Nilchian. Gerresheimer is keen to provide visitors and experts at Iran Health with comprehensive information on its products and services. At this year’s trade fair, the company will be focusing on primary packaging made from amber and clear glass and suitable for drugs in solid or liquid form.
For instance, Gerresheimer manufactures injection and infusion bottles in hydrolytic classes I and II as well as tubular-glass injection vials that can hold between 1 and 50 ml. Its other core products include ampoules, cartridges, and more specialty products.
The Gerresheimer range encompasses all classes of glass used for pharmaceuticals – types II and III sodium silicate glass as well as type I borosilicate glass. This enables the company to supply the perfect glass packaging to suit drugs of any shape or size. Its extensive glass range means that appropriate packaging solutions can be found for even the most sensitive pharmaceuticals.
Gerresheimer employs the latest techniques and monitoring technology from the development stage right through to production and packing for delivery. Some of its plants even have a fully automated system built around packing robots. Gerresheimer uses cutting-edge clean room technology to guarantee optimum cleanliness for its products in terms of particles and germs.
With bases in Europe, Asia, and the Americas, Gerresheimer specializes in manufacturing primary packaging for pharmaceuticals in line with the relevant pharmacopeias. All of its factories are currently certified to standards including ISO 9001 and ISO 15378.
Between May 14 and 17, Gerresheimer’s pharma specialists will be in the "German Pavilion" (B16/b-9) at Iran Health in Tehran, which is being held at the Tehran Permanent Fairground.
Gerresheimer’s primary packaging glass
Gerresheimer is a leading global partner to the pharma and healthcare industries. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
Diese Pressemitteilungen könnten Sie auch interessieren
Weitere Informationen zum Thema "Medizintechnik":
Künstliche Intelligenz optimiert das Mobilfunknetz
Das Mobilfunknetz, ein komplexes Konstrukt aus Mobilfunkstandorten und Netzelementen, sorgt dafür, dass Menschen jederzeit und überall miteinander telefonieren und ihre digitalen Anwendungen nutzen können. Die Instandhaltung, Überprüfung und Optimierung einer solch vielschichtigen Struktur erfordert jede Menge menschliches und technisches Know-how. Um komplexe Zusammenhänge im Mobilfunknetz noch besser zu verstehen, setzt Telefónica Deutschland seit einiger Zeit Algorithmen und Künstliche Intelligenz (KI) ein.Weiterlesen